ScoreWhy is Venus Remedies Ltd ?
1
Company has a low Debt to Equity ratio (avg) at 0 times
2
With a growth in Net Profit of 473.5%, the company declared Very Positive results in Sep 25
- The company has declared positive results for the last 4 consecutive quarters
- PAT(Latest six months) At Rs 29.73 cr has Grown at 528.54%
- PBT LESS OI(Q) At Rs 24.78 cr has Grown at 2073.68%
- ROCE(HY) Highest at 13.99%
3
With ROE of 10.5, it has a Attractive valuation with a 1.7 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 133.40%, its profits have risen by 183% ; the PEG ratio of the company is 0.1
4
Market Beating performance in long term as well as near term
- Along with generating 133.40% returns in the last 1 year, the stock has outperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Venus Remedies should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Venus Remedies for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Venus Remedies
170.5%
2.56
52.12%
Sensex
8.49%
0.43
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
6.29%
EBIT Growth (5y)
29.54%
EBIT to Interest (avg)
37.06
Debt to EBITDA (avg)
0.63
Net Debt to Equity (avg)
-0.37
Sales to Capital Employed (avg)
1.15
Tax Ratio
26.34%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
3.28%
ROCE (avg)
7.85%
ROE (avg)
7.52%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
14
Industry P/E
32
Price to Book Value
1.78
EV to EBIT
9.40
EV to EBITDA
7.43
EV to Capital Employed
2.25
EV to Sales
1.19
PEG Ratio
0.08
Dividend Yield
NA
ROCE (Latest)
19.01%
ROE (Latest)
10.52%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Bullish
Bullish
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend25What is working for the Company
ROCE(HY)
Highest at 13.99%
INVENTORY TURNOVER RATIO(HY)
Highest at 6.58 times
PBDIT(Q)
Highest at Rs 37.52 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 20.81%
PBT LESS OI(Q)
Highest at Rs 30.95 cr.
PAT(Q)
Highest at Rs 25.58 cr.
EPS(Q)
Highest at Rs 19.13
-1What is not working for the Company
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 42.59 cr
Loading Valuation Snapshot...
Here's what is working for Venus Remedies
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 30.95 cr has Grown at 145.63%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 25.58 cr has Grown at 116.9%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Inventory Turnover Ratio- Half Yearly
Highest at 6.58 times and Grown
each half year in the last five half yearly periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Operating Profit (PBDIT) - Quarterly
Highest at Rs 37.52 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 20.81%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 30.95 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 25.58 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 19.13
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Venus Remedies
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 42.59 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
